Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

Tumor cell proliferation requires rapid synthesis of macromolecules including lipids, proteins, and nucleotides. Many tumor cells exhibit rapid glucose consumption, with most of the glucose-derived carbon being secreted as lactate despite abundant oxygen availability (the Warburg effect). Here, we used 13C NMR spectroscopy to examine the metabolism of glioblastoma cells exhibiting aerobic glycolysis. In these cells, the tricarboxylic acid (TCA) cycle was active but was characterized by an efflux of substrates for use in biosynthetic pathways, particularly fatty acid synthesis. The success of this synthetic activity depends on activation of pathways to generate reductive power (NADPH) and to restore oxaloacetate for continued TCA cycle function (anaplerosis). Surprisingly, both these needs were met by a high rate of glutamine metabolism. First, conversion of glutamine to lactate (glutaminolysis) was rapid enough to produce sufficient NADPH to support fatty acid synthesis. Second, despite substantial mitochondrial pyruvate metabolism, pyruvate carboxylation was suppressed, and anaplerotic oxaloacetate was derived from glutamine. Glutamine catabolism was accompanied by secretion of alanine and ammonia, such that most of the amino groups from glutamine were lost from the cell rather than incorporated into other molecules. These data demonstrate that transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools. Rather, glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.

[1]  H. Eagle,et al.  The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. , 1956, The Journal of biological chemistry.

[2]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[3]  O. Warburg On respiratory impairment in cancer cells. , 1956, Science.

[4]  R. Johnstone,et al.  Glutamine metabolism in Ehrlich ascites-carcinoma cells. , 1962, The Biochemical journal.

[5]  A. J. Hale,et al.  Observations on the Proliferation of Human Leucocytes Cultured with Phytohaemagglutinin , 1963, British journal of haematology.

[6]  C. J. Hedeskov Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. , 1968, The Biochemical journal.

[7]  J. Foker,et al.  Aerobic glycolysis during lymphocyte proliferation , 1976, Nature.

[8]  S. Ogawa,et al.  13C NMR studies of gluconeogenesis in rat liver cells: utilization of labeled glycerol by cells from euthyroid and hyperthyroid rats. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[10]  T R Brown,et al.  Cellular applications of 31P and 13C nuclear magnetic resonance. , 1979, Science.

[11]  Z. Kovačević,et al.  Mitochondrial metabolism of glutamine and glutamate and its physiological significance. , 1983, Physiological reviews.

[12]  K. Brand Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. , 1985, The Biochemical journal.

[13]  A. Sherry,et al.  Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy , 1987, FEBS letters.

[14]  V. P. Chacko,et al.  Comparative 13C and 31P NMR assessment of altered metabolism during graded reductions in coronary flow in intact rat hearts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Jacobs,et al.  Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Blanch,et al.  Examination of primary metabolic pathways in a murine hybridoma with carbon‐13 nuclear magnetic resonance spectroscopy , 1994, Biotechnology and bioengineering.

[17]  M. Prados,et al.  Constitutional p53 mutations associated with brain tumors in young adults. , 1995, Cancer genetics and cytogenetics.

[18]  G. Pasternack,et al.  Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. , 1996, Cancer research.

[19]  Gordon Mills,et al.  Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC , 1998, Current Biology.

[20]  R G Shulman,et al.  13C NMR of intermediary metabolism: implications for systemic physiology. , 2001, Annual review of physiology.

[21]  M. Brosnan,et al.  Alanine Metabolism in the Perfused Rat Liver , 2001, The Journal of Biological Chemistry.

[22]  C. Thompson,et al.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. , 2002, Molecular biology of the cell.

[23]  R. Gruetter In vivo 13 C NMR studies of compartmentalized cerebral carbohydrate metabolism , 2002, Neurochemistry International.

[24]  E. Lewandowski Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow? , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[25]  Suzanne Wehrli,et al.  Real‐time detection of 13C NMR labeling kinetics in perfused EMT6 mouse mammary tumor cells and βHC9 mouse insulinomas , 2004 .

[26]  O. Warburg über den Stoffwechsel der Carcinomzelle , 1925, Klinische Wochenschrift.

[27]  Suzanne Wehrli,et al.  Artificial tumor model suitable for monitoring 31P and 13C NMR spectroscopic changes during chemotherapy‐induced apoptosis in human glioma cells , 2005, Magnetic resonance in medicine.

[28]  Daniel E Bauer,et al.  ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.

[29]  R. Deberardinis,et al.  Phosphatidylinositol 3-Kinase-dependent Modulation of Carnitine Palmitoyltransferase 1A Expression Regulates Lipid Metabolism during Hematopoietic Cell Growth* , 2006, Journal of Biological Chemistry.